LDOS vs ORMP
Leidos Holdings Inc (LDOS) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Leidos Holdings Inc (LDOS) is a information technology services company listed on US.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported LDOS revenue for 2025-01-03 was $16.66B. Net income was $1.25B. Revenue was up 7.9% from 2023-12-29 to 2025-01-03. LDOS currently screens at market cap $20.04B and trailing P/E 15.7.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
LDOS currently screens at market cap $20.04B and trailing P/E 15.7. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the LDOS and ORMP stock pages for the full models.
Not investment advice.